Abstract
Wiping out malaria is now the global concern as about three billion people are at risk of malaria infection globally. Despite of extensive research in the field of vaccine development for malaria, till now, no effective vaccine is available for use and hence only antimalarial drugs remain our best hope for both treatment and prevention of malaria. However, emergence and spread of drug resistance has been a major obstacle for the success of malaria elimination globally. This review will summarize the information related to antimalarial drugs, drug development strategies, drug delivery through nanoparticles, few current issues like adverse side effects of most antimalarial drugs, non availability of drugs in the market and use of fake/poor quality drugs that are hurdles to malaria control. As we don’t have any other option in the present scenario, we have to take care of the existing tools and make them available to almost all malaria affected area.
Keywords: Antimalarial drug, development, resistance.
Graphical Abstract
Current Drug Discovery Technologies
Title:Antimalarial Drug: From its Development to Deface
Volume: 12 Issue: 4
Author(s): Tapan Kumar Barik
Affiliation:
Keywords: Antimalarial drug, development, resistance.
Abstract: Wiping out malaria is now the global concern as about three billion people are at risk of malaria infection globally. Despite of extensive research in the field of vaccine development for malaria, till now, no effective vaccine is available for use and hence only antimalarial drugs remain our best hope for both treatment and prevention of malaria. However, emergence and spread of drug resistance has been a major obstacle for the success of malaria elimination globally. This review will summarize the information related to antimalarial drugs, drug development strategies, drug delivery through nanoparticles, few current issues like adverse side effects of most antimalarial drugs, non availability of drugs in the market and use of fake/poor quality drugs that are hurdles to malaria control. As we don’t have any other option in the present scenario, we have to take care of the existing tools and make them available to almost all malaria affected area.
Export Options
About this article
Cite this article as:
Barik Kumar Tapan, Antimalarial Drug: From its Development to Deface, Current Drug Discovery Technologies 2015; 12 (4) . https://dx.doi.org/10.2174/1570163812666150907100019
DOI https://dx.doi.org/10.2174/1570163812666150907100019 |
Print ISSN 1570-1638 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6220 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antiplatelet Treatment in Ischemic Stroke Treatment
Current Topics in Medicinal Chemistry Targeting to 5-HT1F Receptor Subtype for Migraine Treatment: Lessons from the Past, Implications for the Future
Central Nervous System Agents in Medicinal Chemistry Natural Proteinaceous Inhibitors of Serine Proteases
Current Pharmaceutical Design Development of a Definition for the Alcohol Hangover: Consumer Descriptions and Expert Consensus
Current Drug Abuse Reviews Macrophage Activation Syndrome in Childhood Rheumatic Diseases
Current Rheumatology Reviews Emerging Therapies for Diabetic Neuropathy: A Clinical Overview
Current Diabetes Reviews Neurokinin-1 Receptor Antagonists in Lung Cancer Therapy
Letters in Drug Design & Discovery Alterations in Hepatic Lipid Metabolism, and their Relation to Dietary Macronutrients in Pediatric Nonalcoholic Fatty Liver Disease
Drug Metabolism Letters Organic Antifungal Drugs and Targets of Their Action
Current Topics in Medicinal Chemistry History Repeats Itself: Pharmacodynamic Trends in the Treatment of Anxiety Disorders
Current Pharmaceutical Design Psychosocial Stress, Emotions and Cytokine-Related Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Pharmacological Treatment of Cannabis Dependence
Current Pharmaceutical Design Circadian Rhythm in Cytokines Administration
Mini-Reviews in Medicinal Chemistry Retrospective Results on the Treatment of Chronic Hepatitis C with Different Interferon Regimes in a General Hospital
Current Drug Therapy Gene Therapy and Targeted Toxins for Glioma
Current Gene Therapy Resistance to Imatinib in Chronic Myeloid Leukemia and Therapeutic Approaches to Circumvent the Problem
Cardiovascular & Hematological Disorders-Drug Targets Medicinal Properties of the Jamaican Pepper Plant Pimenta dioica and Allspice
Current Drug Targets Patient-Specific Induced Pluripotent Stem Cell Models in Mitochondrial Diseases
Current Stem Cell Research & Therapy 5-HT3 Receptors
Current Drug Targets - CNS & Neurological Disorders New Perspectives in the Pharmacological Treatment of Non-Melanoma Skin Cancer
Current Drug Targets